Evidence map›Paper›PMID 30050123›Full record

ArticleLeukemia2019

Uncoupling of CD71 shedding with mitochondrial clearance in reticulocytes in a subset of myelodysplastic syndromes.

Qi Zhang, David P Steensma, Jingke Yang, Tingting Dong, Mei X Wu

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Leukemia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03720977 (Diagnostic Value and Biological Significant of cd71 in Lymphoid Dis Order), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03720977 unknown statusnot on this map

Diagnostic Value and Biological Significant of cd71 in Lymphoid Dis Order

TypeobservationalSponsorMarwa Aboelim ShafeikRan2019 to 2020Enrolled139ConditionsLyphoid Disorders, cd71
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Qi ZhangWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, USA.
David P SteensmaDana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, MA, 02215, USA.
Jingke YangWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, USA.
Tingting DongWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, USA.
Mei X WuWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, USA. mwu5@mgh.harvard.edu.
Harvard University · USMassachusetts General Hospital · USDana-Farber Cancer Institute · US

Funding

Potentials of a Newly Engineered Device for Treatment of Neonatal ThrombocytopeniaR21HL141016 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WU, MEI X · 2018 to 2019
$458k
IEX-1 as a potential biomarker for early detection of myelodysplastic syndromesR21CA158756 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WU, MEI X · 2011 to 2012
$378k
NCI NIH HHS R21 CA158756NHLBI NIH HHS R21 HL141016U.S. Department of Health & Human Services | National Institutes of Health (NIH) CA158756
6 · The paper itself

Abstract

Reticulocytes shed CD71 from the cell membrane and eliminate mitochondria during terminal maturation, but it is unknown whether these two events are coordinated. We demonstrate that timely removal of CD71 is coupled with mitochondrial clearance, which can be disrupted by null mutation of immediate early response gene X-1 (IEX-1), leading to generation of aberrant CD71-positive and mitochondria-negative (CD71

Indexed as

ErythropoiesisAnimalsAntigens, CDAutophagyCase-Control StudiesHumansImmediate-Early ProteinsMice, Inbred C57BLMice, KnockoutMitochondriaMyelodysplastic SyndromesReactive Oxygen SpeciesReceptors, TransferrinReticulocytesAntigens, CDCD71 antigenIEX-1 protein, mouseImmediate-Early ProteinsReactive Oxygen SpeciesReceptors, Transferrin

Identifiers

PMID30050123
PMCPMC7432991
OpenAlexW2884084891

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.